Evidence map›Paper›PMID 31823956›Full record

ArticleAnnals of African medicine

Development of crohn's disease following treatment for juvenile idiopathic arthritis in a nigerian child: Case report and review of literature.

Oluwafunmilayo Funke Adeniyi, Uyi Ima-Edomwonyi, A Emuobor Odeghe, I Vincent Onyekwelu

Abstract readCase Reports
In one paragraph

Article in Annals of African medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 76% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Oluwafunmilayo Funke AdeniyiDepartment of Paediatrics, Paediatric Gastroenterology Unit, College of Medicine, University of Lagos/Lagos University Teaching Hospital, Lagos, Nigeria.
Uyi Ima-EdomwonyiDepartment of Internal Medicine, Lagos University Teaching Hospital, Lagos, Nigeria.
A Emuobor OdegheDepartment of Internal Medicine, Gastroenterology Unit, College of Medicine, University of Lagos/Lagos University Teaching Hospital, Lagos, Nigeria.
I Vincent OnyekweluDepartment of Histopathology, Clina Lancet Laboratories, Lagos, Nigeria.
University of Lagos · NGLagos University Teaching Hospital · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Juvenile idiopathic arthritis (JIA) and Crohn's disease (CD) are diseases that are rarely seen in the black African child. CD has been reported to occur following therapy with etanercept in JIA patients. We report the case of a Nigerian child with JIA who developed CD following treatment for JIA. A 9-year-old male with JIA was referred to the pediatric gastroenterology unit of the Lagos University Teaching Hospital on the account of chronic diarrhea with occasional passage of bloody stools. He had been on prednisolone and methotrexate which had controlled the joint flares. Colonoscopy revealed extensive colitis, ulcers, abscesses, and ileocecal disease. Histology confirmed the CD. In view of the unavailability of the recommended treatment, namely biologics in the country and financial constraints; steroids; and sulfasalazine were added to his treatment regimen, and subsequently, he has made significant clinical improvement.

Indexed as

Anti-Inflammatory Agents, Non-SteroidalArthritis, JuvenileChildColonoscopyCrohn DiseaseGastrointestinal AgentsHumansMaleMethotrexateNigeriaPrednisoloneSteroidsSulfasalazineTreatment OutcomeAnti-Inflammatory Agents, Non-SteroidalGastrointestinal AgentsMethotrexatePrednisoloneSteroidsSulfasalazineCrohn's diseasejuvenile idiopathic arthritisNigerian child

Identifiers

PMID31823956
PMCPMC6918792
OpenAlexW2994793460

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.